Perry Michael S

SEC CIK: 0001250379

SEC filings (opens in a new tab)

In the past year, 2 open-market sale filings worth $2.00M and no purchases.

Current role at each company

ARWR Arrowhead Pharmaceuticals, Inc.Directoras of Aug 20, 2026
RCEL AVITA Medical, Inc.Directoras of Nov 22, 2022

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: $2.00M; 2 filings
Net: −$2.00M; Bought minus sold
Companies: 1; With open-market trades

Trades

Every Form 4 that lists Perry Michael S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

ARWR Arrowhead Pharmaceuticals, Inc.

Director3 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Jan 4, 2022 (view filing)	Jan 3	1 day	Perry Michael SDirector	SSale	−4.50K	$64.71	−$291.2K	−5.0%85.5K after	3 lots
Dec 9, 2025 (view filing)	Dec 5	4 days	Perry Michael SDirector	SSale	−16.3K	$61.03	−$991.7K	−12.4%115.2K after
Aug 20, 2026 (view filing)5:22 PM ET	Aug 18	2 days	Perry Michael SDirector	SSale	−11.6K	$87.30	−$1.01M	−9.4%111.5K after

RCEL AVITA Medical, Inc.